Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cagol

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2025
Reinforcing the evidence framework for paramagnetic rim lesions in MS: Advancing toward broad clinical integrationAlessandro Cagol, Àlex Rovira
Neurology|January 22, 2026
Turning Our Gaze to the Anterior Visual Pathway: Iron Rim Lesions Come Into View in Multiple SclerosisAlessandro Cagol, Cristina Granziera
Neurology|December 23, 2024
Reassuring Insights Into the Effect of COVID-19 on Symptoms and Disability in People With Multiple Sclerosis: Weathering the StormAlessandro Cagol, Noemi Montobbio
Neuroimaging Clinics of North America|June 28, 2024
Advanced Brain Imaging in Central Nervous System Demyelinating DiseasesAlessandro Cagol, Charidimos Tsagkas, Cristina Granziera
The Lancet Regional Health. Europe|October 13, 2025
The effect of disease-modifying therapies on brain volume loss and disability accumulation in multiple sclerosis: a systematic review and network meta-analysisAlessandro Cagol, Sabine Schaedelin, Roxanne Pretzsch, et al.
Frontiers in Neurology|September 21, 2018
Sporadic MM-1 Type Creutzfeldt-Jakob Disease With Hemiballic Presentation and No Cognitive Impairment Until Death: How New NCJDRSU Diagnostic Criteria May Allow Early DiagnosisLorenzo Saraceno, Vito A G Ricigliano, Michele Cavalli, et al.
Frontiers in Neuroscience|July 31, 2025
A pilot study assessing the clinical utility of deep learning-reconstructed 3D-echo-planar-imaging-based quantitative susceptibility mapping in multiple sclerosisDimitrios G Gkotsoulias, Matthias Weigel, Alessandro Cagol, et al.
Neuroimage. Clinical|July 22, 2025
Fluid and White Matter Suppression contrasts MRI improves Deep Learning detection of Multiple Sclerosis Cortical LesionsPedro M Gordaliza, Jannis Müller, Alessandro Cagol, et al.
JAMA Neurology|October 2, 2023
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic ReviewJannis Müller, Alessandro Cagol, Johannes Lorscheider, et al.
Ebiomedicine|June 24, 2025
Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trialsNoemi Montobbio, Francesca Bovis, Alessio Signori, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2025
Reinforcing the evidence framework for paramagnetic rim lesions in MS: Advancing toward broad clinical integrationAlessandro Cagol, Àlex Rovira
Neurology|January 22, 2026
Turning Our Gaze to the Anterior Visual Pathway: Iron Rim Lesions Come Into View in Multiple SclerosisAlessandro Cagol, Cristina Granziera
Neurology|December 23, 2024
Reassuring Insights Into the Effect of COVID-19 on Symptoms and Disability in People With Multiple Sclerosis: Weathering the StormAlessandro Cagol, Noemi Montobbio
Neuroimaging Clinics of North America|June 28, 2024
Advanced Brain Imaging in Central Nervous System Demyelinating DiseasesAlessandro Cagol, Charidimos Tsagkas, Cristina Granziera
The Lancet Regional Health. Europe|October 13, 2025
The effect of disease-modifying therapies on brain volume loss and disability accumulation in multiple sclerosis: a systematic review and network meta-analysisAlessandro Cagol, Sabine Schaedelin, Roxanne Pretzsch, et al.
Frontiers in Neurology|September 21, 2018
Sporadic MM-1 Type Creutzfeldt-Jakob Disease With Hemiballic Presentation and No Cognitive Impairment Until Death: How New NCJDRSU Diagnostic Criteria May Allow Early DiagnosisLorenzo Saraceno, Vito A G Ricigliano, Michele Cavalli, et al.
Frontiers in Neuroscience|July 31, 2025
A pilot study assessing the clinical utility of deep learning-reconstructed 3D-echo-planar-imaging-based quantitative susceptibility mapping in multiple sclerosisDimitrios G Gkotsoulias, Matthias Weigel, Alessandro Cagol, et al.
Neuroimage. Clinical|July 22, 2025
Fluid and White Matter Suppression contrasts MRI improves Deep Learning detection of Multiple Sclerosis Cortical LesionsPedro M Gordaliza, Jannis Müller, Alessandro Cagol, et al.
JAMA Neurology|October 2, 2023
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic ReviewJannis Müller, Alessandro Cagol, Johannes Lorscheider, et al.
Ebiomedicine|June 24, 2025
Uncovering a bias in estimated treatment effects on PIRA in multiple sclerosis clinical trialsNoemi Montobbio, Francesca Bovis, Alessio Signori, et al.
Pageof 6